MDL Supports Oracle Information Architecture for Life Sciences
'Oracle identified MDL as an early alliance for IALS because the vast majority of life science companies are already using MDL discovery informatics solutions,' said Jon Simmons, vice president of life sciences at Oracle Corp. 'This means that MDL is ideally positioned to assist Oracle in defining the IALS while also helping to promote an open, standards-based Oracle application platform within the life sciences community.'
Speaking at Life Sciences Day during Oracle AppsWorld in April, Lars Barfod, MDL's executive vice president and chief business officer, stressed the improvements in research productivity experienced by many customers who are successfully running MDL solutions on Oracle. Barfod expects MDL(R) Discovery Framework, the company's framework for integrating discovery content, applications, and technologies, to play an important role in IALS. By bringing together Oracle's technology platform for Life Sciences and business objects with MDL's industry-leading chemistry, biology, and ADME/Toxicology objects, Discovery Framework will let MDL customers create solutions that bridge the entire drug development cycle.
Barfod stated: 'This exciting life sciences partnership builds on MDL's very productive 15-year association with Oracle--a mutually beneficial business relationship highlighted by MDL's successful Oracle reselling program and the fact that our product strategy is naturally consistent with Oracle's direction for IALS.'
Most read news
Topics
Organizations
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.